Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

BACKGROUND: Fibroblast growth factor 23 (FGF23), a phosphate-regulating hormone that increases early in the course of chronic kidney disease (CKD), is associated with disease progression in patients with established CKD. Here we aimed to investigate the association between plasma FGF23 and new-onset...

Descripción completa

Detalles Bibliográficos
Autores principales: De Jong, Maarten A, Eisenga, Michele F, van Ballegooijen, Adriana J, Beulens, Joline W J, Vervloet, Marc G, Navis, Gerjan, Gansevoort, Ron T, Bakker, Stephan J L, De Borst, Martin H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771975/
https://www.ncbi.nlm.nih.gov/pubmed/32124925
http://dx.doi.org/10.1093/ndt/gfz266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771975/
https://www.ncbi.nlm.nih.gov/pubmed/32124925
http://dx.doi.org/10.1093/ndt/gfz266

Ejemplares similares